Exploring the impact of silymarin on the risk of cataract in patients with chronic hepatic diseases

Exploring the impact of silymarin on the risk of cataract in patients with chronic hepatic diseases

碩士 === 臺北醫學大學 === 藥學系(碩博士班) === 102 === Background:Reduced levels of glutathione in patients with chronic liver disease lead to oxidative stress in crystalline lens proteins.Because few past retrospective cohort studies exist,the purpose of this study was to investigate the effects of silymarin on t...

Full description

Bibliographic Details
Main Authors:	Jih-Rong Yang, 楊季蓉
Other Authors:	廖嘉鴻
Format:	Others
Language:	zh-TW
Published:	2014
Online Access:	http://ndltd.ncl.edu.tw/handle/f66neg

Similar Items

Exploring the Impact of Silymarin on the Risk of Age-related macular degeneration in Patients with Chronic Hepatic Diseases
by: Li- Fen Lee, et al.
Published: (2018)

Silybin/Silymarin treatment in chronic hepatitis C
by: Varenka J. Barbero-Becerra, et al.
Published: (2012-09-01)

Study of Hepatoprotective Effect of Silymarin and Ursodeoxycholic Acid in Chronic Hepatitis C Patients
by: Shahira Fawzy El Menshawe, et al.
Published: (2014-12-01)

The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial
by: Fahimeh Kaveh Baghbahadorani, et al.
Published: (2017-08-01)

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
by: Alessandro Federico, et al.
Published: (2017-01-01)

Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials
by: Zongguo Yang, et al.
Published: (2014-01-01)

The impact of Silymarin on improvement of platelet abnormalities in patients with severe preeclampsia
by: Fahimeh Kaveh Baghbahadorani, et al.
Published: (2016-05-01)

The Effect of Silybum marianum (L.) Gaertn. Seed Extract (Silymarin) on Galactose Induced Cataract Formation in Rats
by: H Fallah Huseini, et al.
Published: (2009-02-01)

Ameliorative effect of liquorice extract versus silymarin in experimentally induced chronic hepatitis: A biochemical and genetical study
by: H.A. Abdel Maksoud, et al.
Published: (2019-02-01)

2,3-Dehydroderivatives of Silymarin Flavonolignans: Prospective Natural Compounds for the Prevention of Chronic Diseases
by: Kateřina Valentová, et al.
Published: (2019-04-01)

Hepatoprotective activity of silymarin encapsulation against hepatic damage in albino rats
by: Shanza Mukhtar, et al.
Published: (2021-01-01)

Investigating the impact of silymarin on liver oxidative injury
by: Mohammad Jamalian, et al.
Published: (2020-01-01)

Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
by: Hong Guo, et al.
Published: (2019-05-01)

Therapeutic Use of Silymarin in the Management of Suspected Renal and Hepatic Injury Produced by NSAIDs in Osteoarthritis Patients
by: Saad A. Hussain, et al.
Published: (2017-03-01)

Effects of Silymarin on Hyperglycemia
by: Chein-Yu Huang, et al.
Published: (2005)

Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial
by: Yakoot Mostafa, et al.
Published: (2012-04-01)

Frequency of Hepatitis B and Hepatitis C among Cataract Patients
by: Iftikhar Ahmad, et al.
Published: (2004-06-01)

Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation
by: Yang KY, et al.
Published: (2013-08-01)

Effect of Ribavirin Alone or Combined with Silymarin on Carbon Tetrachloride Induced Hepatic Damage in Rats
by: Omar M.E. Abdel Salam, et al.
Published: (2007-01-01)

Effect of Ribavirin Alone or Combined with Silymarin on Carbon Tetrachloride Induced Hepatic Damage in Rats
by: Omar M.E. Abdel Salam M.D., Ph.D., et al.
Published: (2007-01-01)

Hepatoprotective effects of silymarin on CCl4-induced hepatic damage in broiler chickens model
by: A. Baradaran, et al.
Published: (2019-01-01)

Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice
by: Jakub Šuk, et al.
Published: (2019-01-01)

Analgesic effect of silymarin in chicks
by: Ahmed Salah Naser, et al.
Published: (2019-09-01)

Advances in pharmacological studies of silymarin
by: Yao-Cheng Rui
Published: (1991-01-01)

Antiviral Activities of Silymarin and Derivatives
by: Ching-Hsuan Liu, et al.
Published: (2019-04-01)

Impact of Silymarin enriched semen extender on bull sperm preservability
by: R I El-Sheshtawy, et al.
Published: (2017-01-01)

Risk of cataract in the context of acute and chronic exposure
by: Tukov A.R., et al.
Published: (2016-12-01)

The effect of silymarin on non-alcoholic fatty liver disease of children
by: Fatemeh Famouri, et al.
Published: (2017-01-01)

Silymarin-Loaded Nanoparticles Based on Stearic Acid-Modified Bletilla striata Polysaccharide for Hepatic Targeting
by: Yanni Ma, et al.
Published: (2016-02-01)

Metabolic Effects of Quetiapine and the Modulation Role of Silymarin in Schizophrenia Patients
by: Shu-Huey Huang, et al.
Published: (2006)

Effect of chronic administration of Silymarin on oxidative stress markers in renal tissue of diabetic Rats
by: Roghani M (PhD), et al.
Published: (2012-05-01)

Teratogenic effects of silymarin on mouse fetuses
by: Mahbobe Gholami, et al.
Published: (2016-08-01)

Prevalence of Hepatitis ‘B’ and Hepatitis ‘C’ among preoperative cataract patients in Karachi
by: Naeem Syed, et al.
Published: (2012-09-01)

Effects of Silymarin on Hepatitis C Virus and Heme Oxygenase-1 Gene Expression in Human Liver Cells
by: Bonifaz Peña, Vania Elvira
Published: (2007)

FREQUENCY AND RISK FACTORS OF HEPATITIS B AND C VIRUS INFECTIONS IN PATIENTS UNDERGOING CATARACT SURGERY
by: Sardar Bahadar Khan, et al.
Published: (2014-01-01)

Protective effects of chronic administration of silymarin on blood glucose and lipids and oxidative stress in diabetic rats
by: Tourandokht Baluchnejadmojarad, et al.
Published: (2009-02-01)

Threapeutic effects of Salvia milltiorrhiza and silymarin on the mitochondrial dysfunctions in chronic bile-duct ligated rats
by: Chien-Tzu Liu, et al.
Published: (2001)

Silymarin therapy and improvement of cardiac outcome in patients with β-thalassemia major
by: Hadi Darvishi Khezri, et al.
Published: (2016-01-01)

The possibilities of silymarin extract use in alcoholic liver disease – a literature review
by: Aleksandra Kołota
Published: (2017-09-01)

Pharmacokinetic Interaction Between Oltipraz and Silymarin in Rats
by: Min Kyung Kang, et al.
Published: (2009-02-01)

Cannot write session to /tmp/vufind_sessions/sess_1q178bprel3rn45s4rr91519id